LncRNA PDIA3P1 could stabilize C/EBPβ protein by disrupting the C/EBPβ- MDM2 complex and avoiding ubiquitination of C/EBPβ protein by MDM2, which reduces the sensitivity of glioma cells to temozolomide treatment [60]. Here, MDM2 is linked to central nervous system cancer.